DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $250 | +133.6% | 5,378 | +44.3% | 0.00% | +100.0% |
| Q1 2023 | $107 | -26.2% | 3,726 | -19.9% | 0.00% | 0.0% |
| Q4 2022 | $145 | -99.8% | 4,653 | +29.4% | 0.00% | 0.0% |
| Q3 2022 | $73,000 | +30.4% | 3,596 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $56,000 | +43.6% | 3,596 | +77.2% | 0.00% | – |
| Q1 2022 | $39,000 | – | 2,029 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Northpond Ventures, LLC | 3,292,871 | $83,343,000 | 29.17% |
| Sands Capital Ventures, LLC | 3,148,970 | $79,700,000 | 11.81% |
| OUP Management Co., LLC | 536,693 | $13,584,000 | 6.12% |
| New Leaf Venture Partners, L.L.C. | 556,693 | $14,090,000 | 5.10% |
| Logos Global Management LP | 1,664,251 | $42,122,000 | 4.34% |
| Asymmetry Capital Management, L.P. | 185,201 | $4,687,000 | 2.49% |
| Deep Track Capital, LP | 1,341,004 | $33,941,000 | 2.40% |
| RA Capital Management | 5,208,911 | $131,838,000 | 2.32% |
| Soleus Capital Management, L.P. | 810,940 | $20,525,000 | 2.06% |
| Miller Investment Management, LP | 180,901 | $4,579,000 | 0.66% |